E-Book | October 1, 2020

Clinical Trials and a Pandemic: Managing Studies And The Impact of COVID-19

Source: Clinical Leader
20_10_CL_ClinicalTrialsPandemic_Ebook_450x300

Conducting clinical trials is always a challenge. From protocol development to patient recruitment, the gathering of accurate and reliable data, and the regulatory oversight, trials are a lengthy and expensive process.

Then along came COVID-19. When the pandemic hit the U.S. in March 2020, many hospitals, clinics, and sponsor companies were caught by surprise. The effort to protect patients and keep them away from clinics put many trials in jeopardy. Amidst the chaos, sponsors and regulators were able to scramble and keep many trials going while considering the safety and needs of participants. 

In this collection of articles from Clinical Leader, learn how companies not only survived, but created new policies that will be tomorrow’s best practices.

VIEW THE E-BOOK!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: